marketshareAI
Theme

EMV Capital

EMVCFinancial Services
57.50GBX
0.88%
Market Cap
15.97M
Volume
54.13k
158% of avg
P/E Ratio
-9.47
EPS (TTM)
-6.07
Beta
0.54
Day Range
55.00p - 58.84p
52 Week Range
34.00p57.50p58.84p
57.50p

Upcoming Events

31 December 2025
Expected date for full year 2025 results
High Impact Event
Early Q1 2026
Potential trading update for FY 2025
High Impact Event
Late June 2026
End of current funding runway
High Impact Event
June 30, 2026
Completion of Phase 3 clinical trial for XF-73
High Impact Event
March 31, 2027
Potential US regulatory approval for XF-73
High Impact Event
EMVC
NEUTRAL

EMV Capital Announces Director Dealings

The asset management firm has announced a change in shareholding by one of its directors.

EMVC
NEUTRAL

EMV Capital Expands Senior Finance Leadership Team

The deep tech and life sciences VC investment group is expanding its senior finance leadership team with the appointment of a new Group CFO and the creation of a Portfolio CFO role.

EMVC
NEUTRAL

EMV Capital Hosts Virtual Meet the Portfolio Event

The venture capital firm is hosting a virtual event to provide investors with insights into two of its portfolio companies.

EMVC
BAD

EMV Capital Reports Challenging H1 2025 Amid Market Headwinds

The venture capital firm reported a challenging first half of 2025, with decreased revenue and a significant drop in cash position amid persistent market headwinds and limited capital availability.

EMVC
GOOD

EMV Capital Acquires Assets of Destiny Pharma's XF-73 Antibiotic Platform

The venture capital firm has acquired the assets of a novel antibiotic platform from a company in liquidation, with the potential to develop a product that could address the growing threat of antimicrobial resistance.

EMVC
NEUTRAL

EMV Capital Announces Interim Results Presentation

The venture capital firm will release its interim results on 30 September and hold an online investor presentation the same day.

EMVC
NEUTRAL

EMV Capital Announces Office Move and Related Party Transaction

The venture capital firm has entered into a licence agreement to share office space with a company owned by a substantial shareholder.

EMVC
NEUTRAL

EMV Capital Announces Director Dealings

The asset management firm has announced changes to its major shareholdings.

EMVC
NEUTRAL

EMV Capital Announces AGM and Annual Report Release

The venture capital firm has released its annual report and announced its upcoming annual general meeting.

EMVC
NEUTRAL

EMV Capital Directors Increase Shareholdings

The deeptech and life sciences VC investment group announces its CEO and Executive Director have purchased additional shares in the company.